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ABSTRACT 
Seasonal influenza A virus (IAV) infections and their associated respiratory 
diseases are the cause of an estimated 650,000 deaths each year, according to the World 
Health Organization. The zebrafish (Danio rerio) is a powerful vertebrate model to study 
innate immune function and host-pathogen interactions as the function of neutrophils and 
other phagocytes can be characterized in vivo. Preliminary studies have shown an 
increase in neutrophil respiratory burst activity to eliminate the invading pathogen, yet 
little is known of all of the mechanisms involved in neutrophil function. The NADPH 
oxidase complex, of which neutrophil cytosolic factor 1 (Ncf1) is a key component, 
regulates reactive oxygen species (ROS) to control neutrophil response to viral infection. 
Although necessary to fight infection, this elicits a hyperinflammatory response that can 
damage the infected host epithelial tissue, leaving high-risk individuals with increased 
mortality rates.  
Our hypothesis is that a fully functional Ncf1 protein is required for neutrophil 
function, but morpholino knockdown of the gene will limit the amount of damaging ROS 
hyperinflammation in host tissue. Our preliminary studies of systemic IAV infected 
embryos indicate that the survival of ncf1 morphants was increased compared to standard 
morphant control groups. Fluorescence confocal imaging and TCID50 assays reveal a 
decreased viral burden in ncf1 morphant groups compared to control morphant groups 
over a span of 96 hours post-infection. Finally, qRT-PCR studies assay the expression of 
nrf2, mxa, and cxcl8b revealing decreased expression of each gene in ncf1 morphants 
compared to controls. These studies aim to increase our understanding of neutrophil 
function that may eventually lead to new therapies for treating IAV infection. 
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INTRODUCTION 
 
 
The Impact of Influenza A Virus (IAV) 
Seasonal influenza infections and their associated respiratory diseases are the 
cause of an estimated 650,000 deaths each year, according to the World Health 
Organization. Most infected individuals recover within a week of symptom onset. 
However, high-risk individuals—such as the elderly, pregnant women, and infants—are 
susceptible to the systemic spread of IAV, causing severe illness or death [1]. Since 1889, 
six influenza pandemics have plagued the Northern Hemisphere, the most recent being a 
deadly outbreak of influenza A (H1N1)pdm09 virus in 2009 [2]. The 2009 pandemic alone 
resulted in over 60.8 million cases and about 12,500 deaths in the United States [3]. 
Seasonal flu vaccines are helpful in diminishing the spread of infection, but developing 
effective vaccines requires accurate prediction of which strains will be most prevalent in 
advance of each year’s flu season. Antigenic drift of the virus’ genome makes yearly 
vaccine design difficult and the risk of pandemics high, highlighting a clear need for 
alternative therapies. 
Influenza viruses belong to the Orthomyxoviridae family and can be organized 
into four different types: A, B, C, and D [4]. This categorization is derived from antigenic 
differences between the virus’ nucleoproteins and matrix M1 proteins, as well as 
differences in viral reassortment [5]. Influenza A, B, and C viruses each have the ability to 
infect humans, with A and B strains acting as the main causes for seasonal outbreaks [4]. 
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 Each type of influenza virus can be further classified by its surface neuraminidase 
(NA) and hemagglutinin (HA) proteins (Fig. 1). NA is responsible for cleaving sialic acid 
linkages of host cell interior glycoproteins. This allows the newly replicated virus to 
escape the host. HA is used for the recognition and binding of these sialic acid linkages. 
Currently, 18 HA and 11 NA subtypes have been identified for IAV. Within these 
subtypes, humans are affected by H1, H2, or H3, and N1 or N2 [7]. Large changes in 
genome sequence caused by genetic reassortment between animal and human HA 
subtypes result in an antigenic shift. Although rare, this results in an entirely new strain 
and pandemic. Such was the case of the 2009 (H1N1)pdm09 swine flu [7]. Alternatively, 
antigenic drift of these subtypes occurs when singular point mutations minorly alter these 
surface proteins of influenza, allowing for it to evade recognition by the immune system. 
With this ability, one strain of IAV can cause recurrent outbreaks throughout a population 
through constant change in its surface protein presentation. The most prevalent seasonal 
outbreak strains of IAV are H1N1 and H3N2 subtypes [4]. Due to the ever-changing 
Fig 1. Structure of IAV. A) The IAV genome encodes for the M2 ion channel, 
neuraminidase, and hemagglutinin envelope proteins along with various nonstructural 
proteins. B) Hemagluttanin is a homotrimeric protein [6]. 
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nature of IAV, it is imperative to develop novel treatments and therapies against the 
pathogen. 
 
The Innate Immune Response 
When infected by a pathogen, humans rely on two immune responses: The innate 
and the adaptive response. The innate immune response is conserved within all plant and 
animal species, while the adaptive immune system is not. As a rapid and nonspecific 
response, the innate immune system acts as the first responder to infection. It 
encompasses not only physical and chemical barriers to disease, such as the skin and 
sweat pH in humans, but also cellular responses [8]. When invading pathogens bypass an 
animal’s physical barriers, the innate immune system will employ proinflammatory 
cytokine signaling to sites of infection, recruiting phagocytic cells. Pattern recognition 
receptors (PRRs) are used by innate immune cells in order to recognize highly conserved 
structures on the outside of microbial species. These structures are called pathogen-
associated molecular patterns (PAMPs) [9]. The recognition of specific PAMPs allows the 
immune system to not only differentiate invading cells from the host’s own cells, but it 
also triggers pathogen-specific cytokine signaling. Within minutes of recognition, cellular 
signaling cascades cause the upregulation of proinflammatory and cytokine signaling to 
further recruit innate immune phagocytes to rid the host of the pathogen. 
 As part of the innate immune response, phagocytic cells known as neutrophils are 
some of the first responding cells to pathogen invasion. This occurs in a rapid succession 
of events. First, neutrophils are recruited from the bone marrow, followed by accelerated 
hematopoiesis to generate new blood cells. Next, the neutrophils will relocate to the 
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host’s bloodstream and marginate along vasculature walls proximal to the site of 
infection. Finally, through diapedesis, the neutrophils will migrate out of the vasculature 
towards the infection site [10]. At this point, the neutrophils will be able to interact with 
and phagocytose the invading pathogen. 
The neutrophil response to IAV follows this same process. During phagocytosis, 
neutrophils will utilize the production of toxic oxygen metabolites to fight infection 
through a process known as respiratory burst. Although necessary to clear invading 
pathogens, this elicits a hyperinflammatory response that can damage the infected host 
epithelial tissue, leaving high-risk individuals with increased mortality rates [11]. This 
damage is, in part, due to reactive oxygen species (ROS) generated by neutrophils near 
virus-infected cells. ROS are a group of highly reactive molecules that are mainly 
produced by phagocytes [12, 13]. At low concentrations, ROS can act as signaling 
molecules, but at a high concentration have the power to oxidize proteins and lipid 
components of cells, causing tissue and DNA damage [14]. ROS are generated by the 
NOX2 NADPH oxidase complex, of which the neutrophil cytosolic factor 1 (ncf1) gene 
encodes a key component. 
 
The NOX2 NADPH Oxidase Complex and ncf1 
In order to produce ROS, neutrophils utilize the NOX2 NADPH oxidase complex. 
There are seven members of the NOX family, including NOX1-5 and DUOX1 and 2. The 
NOX2 NADPH oxidase complex is the predominant ROS producer in humans [15]. This 
complex consists of a Nox2 transmembrane electron carrier that is stabilized and 
activated by four subunits (p22, p47, p67, and Rac2) (Fig. 2) [12]. Nox2, also known as 
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the cytochrome b-245 heavy chain, is the phagosome membrane-bound component of the 
NADPH oxidase complex and consists of the functional transmembrane heterodimers 
gp91phox and p22phox [13]. While dormant, Nox2 will remain within intracellular vesicle 
membranes, while the other components remain trimerized in the cytosol [13].  
 Once activated during phagocytosis, GDP-Rac2 is converted to GTP-Rac2, which 
allows for it to be translocated to the phagosome membrane from the cytosol, along with 
Nox2 from the vesicle membrane [16]. At the same time, the p47phox subunit (which is 
encoded by the ncf1 gene) undergoes a conformational change caused by 
phosphorylation. This exposes two SRC-homology 3 regions that can interact with a 
proline-rich motif on the p22phox subunit of Nox2 [13]. Additional Phox homology 
domains exposed on p47phox can bind to phosphatidylinositol 3-phosphate (PI(3)P) and 
PI(3,4)P2, which are produced at the plasma membrane during phagocytosis. This allows 
for further stabilization with Nox2 at the plasma membrane [15]. Once the complex is 
assembled, the gp91phox subunit converts NADPH to NADP+, freeing two electrons to be 
Fig. 2 NOX2 
NADPH oxidase 
complex. A) 
Complex in resting 
stage. B) Once 
activated, regulatory 
subunits migrate to 
the membrane. C) 
The complex 
produces ROS to 
fight an invading 
pathogen [13]. 
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transported through the Nox2 complex into the phagosome. There, they react with 
molecular oxygen to create ROS [12]. 
 The NOX2 NADPH oxidase complex may have many implications in neutrophil 
antiviral and antioxidant immune responses to infection. Specific subunits of this 
complex may prove to be key modulators of these functions. p47phox, now commonly 
known as Ncf1, is a key activator of the NOX2 oxidase complex. Knockdown of ncf1 
expression has been shown to not only hinder an organism’s ability to produce 
superoxide anions but also creates a loss of phagocyte recruitment to sites of infection 
[17]. Not only does it play an integral role in the production of pathogen-fighting ROS, but 
it can act as a key regulator of the antioxidant response to ROS. For example, to 
counteract the overproduction of tissue-damaging ROS Ncf1 activates Nrf2 (an 
antioxidant transcription factor) and therefore increases antioxidant expression. Previous 
studies have shown that a decrease of ncf1 expression decreases Nrf2 activation, while 
the other NOX2 subunits have no effect [18]. Ncf1 is a novel target for alternative IAV 
therapies, as it plays a critical role in neutrophil function. 
 
The Zebrafish Model 
The use of in vivo animal models in biomedical research allows for the study of 
the pathogenesis of human diseases at both the cellular and organismal levels. Being able 
to observe the effects of pathogens in organisms allows for the characterization of their 
effects on living systems, a distinct advantage over the use of in vitro cell or tissue 
culture. Mammalian models, such as mice and rats, are commonly used in biomedical 
research due to their genetic and anatomical similarities to humans. However, they pose 
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financial and physical restraints such as long gestation periods [19]. Invertebrate models 
cost less to maintain, but lack many organ systems to model disease pathology. 
The zebrafish (Danio rerio) is a powerful vertebrate model to study human 
disease. Zebrafish have been used to model embryonic development since the 1930s [19]. 
Their optical clarity and ease of cellular manipulation are useful for biological research. 
The model was further developed in the 1980s with the advent of genetic techniques such 
as mutagenesis, making zebrafish a standard model in developmental biology. With high 
fecundity of over 100 embryos per clutch and ease of genetic manipulation through either 
morpholino (MO) gene knockdown (KD), or transgenesis, such as CRISPR knockout 
(KO), zebrafish encompass the ease of use. Like other vertebrate models, zebrafish share 
high (70%) genetic and organ system homology to humans, making them ideal for 
modeling infection (Fig. 3) [19]. 
 
 
 
 
 
 
 
 
 
Zebrafish are well-established models for infectious disease, especially for the 
innate immune response. They share high similarity with the human innate immune 
system, containing many of the same responding cell types including neutrophils, 
macrophages, and Natural Killer cells. Cytokine signaling pathways are also highly 
conserved [20]. The zebrafish innate immune system is fully functional by 48 hours post-
fertilization (hpf), allowing researchers to observe immune cell response during early 
larval development. Furthermore, their adaptive immunity does not develop until 4 – 6 
Fig. 3 Zebrafish anatomy taken at 6 days post-fertilization (dpf) with 
brightfield microscopy. Scale bar is 1 mm [20].  
 
8 
 
weeks post-fertilization, allowing for no interference with the innate immune  
response [20]. 
 Previously, the Dr. Carol Kim lab at the University of Maine has established the 
zebrafish as a novel model for IAV infection [21]. Not only do cells in the zebrafish have 
α-2,6 sialic acid linkages on the surface required for human IAV hemagglutinin proteins 
to bind—which other animal models, such as mice, may lack [22]—, but they also display 
tissue-destruction pathology similar to that of IAV infected human patients [21]. Zebrafish 
also exhibit characteristic signs of IAV infection, such as edema and hyperinflammation 
(Fig. 4). Influenza infection can cause acute respiratory distress syndrome (ARDS). One 
of the driving features in the pathogenesis of ARDS is the accumulation of fluid in the 
alveoli, which causes severe pulmonary edema. In zebrafish, a similar effect is 
characterized by a pericardial effusion from the yolk sac. 
 
Furthermore, zebrafish larvae are relatively transparent, allowing for observation 
and imaging of fluorescent IAV strains and the resulting neutrophil response. Zebrafish 
have also been verified as effective models of Pseudomonas aeruginosa infection by the 
Kim lab, and fungal Candida albicans infection by the Dr. Robert Wheeler lab of the 
University of Maine [17].  
 Although the zebrafish model has its advantages, it also has disadvantages. As a 
new model, relative to well-established models such as the mouse, zebrafish have fewer 
Fig. 4 Zebrafish 3 dpf 
exhibiting edema and 
hyperinflammation. A) 
Edema exhibited by a 
pericardial effusion, 
indicated by the black 
arrow.  
B) Hyperinflammatory 
response. 
A 
B 
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available mutant and transgenic strains, as well as fewer known antibodies for use [20]. 
They also have various duplicate genes, which makes forward-reverse genetic 
manipulation difficult [20]. Finally, they thrive in markedly different conditions than 
humans do. They require an environment with high salinity, as well as a temperature 
between 25 – 31℃ for adult fish and 25 – 33℃ for embryos [23]. Each is lower than the 
ideal human temperature of 37℃ [19]. 
 Despite its disadvantages, the zebrafish model is well suited for IAV studies. 
Other animal models, such as mice, ferrets, and guinea pigs have been used with IAV 
infection. For example, ferrets also have α-2,6 sialic acid linkages on the surface of cells, 
allowing human IAV to effectively infect cells [22]. They are able to provide insight into 
not only an immune response, but also how IAV affects organ systems similar to that of a 
human. However, much like other models, zebrafish also display tissue-destruction 
pathology similar to that of IAV infected human patients [21]. The transparency of 
zebrafish larvae is an advantage over other models, as this allows for observation and 
imaging of fluorescent IAV strains and the resulting neutrophil response in vivo of the 
entire organism, without the need of tissue sample removal. The innate immune response 
can also be observed unaffected by the adaptive response until about a month post 
fertilization. Finally, the high fecundity allows for extensive experimentation. Ferrets for 
example, generally have fewer than ten kits per litter, while zebrafish have about 100 
embryos per clutch. Zebrafish require less space, food, and resources to rear than ferrets 
and other mammalian models, allowing for more specimens to study. 
The zebrafish innate immune response is a well-known model for the human 
response, but it is not fully characterized. The exact mechanisms and signaling pathways 
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involved in neutrophil chemotaxis and general response to influenza A infection are not 
fully understood. This study aims to further characterize the role of ncf1 during the 
zebrafish innate immune response to IAV infection. The hyperinflammatory response and 
the NOX oxidase complex can be damaging to host tissue, but it may play a critical role 
in the response to IAV. As a key activating subunit of NOX2, ncf1 provides a novel 
target of study of the modulation of ROS production. Using morpholino KD of ncf1, we 
hope to determine the role of Ncf1 in infection and provide new avenues for future 
genetic therapies against viral infection and hyperinflammation. 
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MATERIALS AND METHODS 
 
 
Zebrafish Care and Maintenance 
Embryos were collected at the 1 cell stage from spawning wild-type AB and 
Tg(mpx:GFP) zebrafish. Embryos were stored in 50 mL of egg water (60 mg/L Instant 
Ocean, Spectrum Brands, Madison, WI) at 33°C.  
 
Microinjection 
At the 1 - 8 cell stage (0.5 to 1 hpf), embryos were injected with 1 nL of either 
standard control, p53, or ncf1 MO (Gene Tools, LLC, Philomath, OR) at concentrations 
of 100-200 μM/nL. The ncf1 MO mix contained equal concentrations of E4I4 and 
translational MO. An additional group was coinjected with both p53 and ncf1 MO. 
Following injections, dead embryos were removed from each group, the egg water 
replaced, and the fish returned to an incubator and held at 33°C. 
For systemic IAV infection at 48 hpf, larvae were dechorionated and anesthetized 
in 200 mg/L tricaine/egg water solution. Infection groups are separated into live virus, 
heat-inactivated virus, UV-inactivated virus, and mock infection. Chilled Influenza 
A/PR/8/34 (H1N1, EID50 5.5x104) in 1X HBSS with phenol red was injected into the 
duct of Cuvier to cause systemic infections in experimental groups. For mock infection 
controls, Hank’s Balanced Salt Solution (HBSS) with phenol red was injected in the same 
manner. Systemic injections were in 1 nL doses. 
Localized infections to the swimbladder were injected at 96 hpf with mCherry 
ColorFlu IAV [24]. Mock infection controls were injected with HBSS. Localized 
injections were administered in 3 consecutive 5 nL doses. 
12 
 
Survival Curves 
Following duct of Cuvier injections in 48 hpf embryos, the survival rates of fish 
in each sample group were measured on a daily basis over a span of 6 days post-
infection. Deceased fish were removed from plates at each 24-hour timepoint. The 
amount alive for the day divided by the total sample at day 0 constitutes the day’s 
survival percentage. Survival curve data and significance were recorded and graphed 
using GraphPad Prism 8 (GraphPad Software, San Diego, California USA, 
www.graphpad.com). 
 
TCID50 
Embryos were injected with either a standard control, ncf1, or ncf1/p53 MO. At 
48 hpf, these groups were split into three equal cohorts infected with either live influenza 
virus, heat-inactivated virus, or HBSS mock infection. Immediately after infection, 6 fish 
were collected from each group by anesthetizing in 400 mg/L tricaine/egg water solution 
and suspended in 500 μL RNALater solution before being flash-frozen for future use. 
Collection was repeated at 24, 48, 72, 96, and 120 hours post-infection (hpi).  
Madin-Darby Canine Kidney London line (MDCK-London) cells were grown in 
T175 flasks in MEM-NCS for use. Cells were then plated into 96-well plates at 50% 
confluency. For an experimental set of 0-96 hpi time points, a total of 6 plates were 
plated. MEM-BSA was prepared with 0.5 mg/mL TPCK-Trypsin from 1 mg/mL aliquots 
1:2000 and kept chilled. 
The frozen fish samples were defrosted, the RNALater solution was removed, and 
300 μL of the MEM-BSA/TPCK-Trypsin added to each tube. The fish were 
homogenized for 4 min. at 4°C. Serial dilutions of the samples were performed with 450 
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mL MEM-BSA/TPCK-Trypsin media to 50 mL of slurry from 10-1 to 10-7 for IAV 
samples and 30 mL of slurry to 270 mL of MEM-BSA/TPCK-Trypsin media for HBSS 
and heat-inactivated samples.  
The MDCK-London cells were then rinsed twice with cold 1x PBS. The serial 
dilutions were then added in 35 μL to the plated MDCK-London cells in triplicate. The 
plates were centrifuged for 5-10 minutes at 4°C, 2,000 g. Plates were then placed on a 
rotator at 4°C for 30 min., tapping in 15 min. intervals. Next, they were transported to a 
rotator at 33°C for 60 min., with tapping at 10 min. intervals. Once incubation was 
complete, the media was removed and 100 μL fresh MEM-BSA/TPCK-Trypsin was 
added to each well. Plates were placed in 37°C incubation for 3-5 days and observed 
every 24 hours for cytopathic effects. TCID50 was determined using the Spearman and 
Kärber method. 
 
qPCR 
Sample groups consisted of standard control or ncf1 morphant fish, each infected 
with either live influenza virus or HBSS mock infection. Each treatment group replicate 
contained 6 fish. Larvae were collected 24 hpi and euthanized in 400 mg/L tricaine/egg 
water solution and suspended in 125 μL of Trizol before being flash-frozen for future use. 
RNA was extracted from sample groups using the Zymo Research Micro Prep Kit as per 
the manufacturer’s instructions. Sample concentrations were determined with the 
ThermoFisher Scientific NanoDrop One and stored in -80°C until needed. cDNA was 
synthesized from extracted RNA with the NEB ProtoScript II cDNA Synthesis Kit 
according to the manufacturer’s instructions with the oligo dT23 variation. 
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For each gene of interest, 100 μM forward and reverse oligos (IDT, Iowa City, 
IA) were added in 5 μL aliquots each to an Eppendorf tube followed by 90 μL of 
DNase/RNase free water and vortexed. β-actin was used as a known control. A master 
mix was created for each gene of interest. For each reaction: 5 μL SsoAdvanced 
Universal SYBR Green Supermi (BioRad, Hercules, CA), 3.5 μL nuclease-free water, 
and 0.5 μL forward/reverse oligo mixture were combined into a master mix tube. A 96-
well plate was labeled for each sample group and replicate. The master mix was added to 
each sample well in 9 μL volumes. Sample cDNA for the samples and no-RT controls 
were added to each appropriate plate, vortexing the sample tubes before addition. Once 
all cDNA has been added, the plate was covered with adhesive film for BioRad qPCR 
plate, vortexed, and spun in the centrifuge. The plate was placed in a BioRad CFX96 
plate and the thermocycler programmed for the following: 10 min. at 95°C; 30 sec. at 
95℃, 1 min. at 55℃, 1 min. at 72℃, 40 times; 1 min. at 95°C; 30 sec. at 55°C; 30 sec. at 
95°C; Hold.  
 
Imaging 
Tg(mpx:GFP) zebrafish were infected with mCherry ColorFlu IAV (Fukuyama et 
al, 2015) or HBSS control at 4 dpf. Images were obtained using the Olympus Fluoview 
1000 on an Olympus IX-81 inverted microscope at 20X magnification. Samples were 
mounted in 0.8% agarose solution on a 24-well glass-bottom plate. 
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RESULTS 
 
 
Ncf1 Knockdown Results in Significantly Increased Survival of AB Zebrafish 
In order to preliminarily gauge the effect ncf1 knockdown has on zebrafish 
survival, three replicate survival trials were conducted comparing wild-type (WT), 
scrambled control morphant, p53 control morphant, ncf1 morphant, and ncf1/p53 
morphant groups. Some morpholinos can induce apoptosis in morphants and the p53 
morpholino has been shown to diminish off-target cell death [25]. To study this effect in 
ncf1 morphants, a ncf1/p53 coinjection group is included in the study, as well as a group 
only injected with p53 as a control. Embryos from each group were infected with either 
HBSS or live IAV.  
All groups injected with HBSS vehicle control had the same rates of survival 
(Fig. 5A). As expected, the scrambled control and WT morphant groups had similar rates 
of survival near 60% (Fig. 5B). After a 6-day observation period, ncf1 morphant survival 
fell to roughly 75% with IAV infection, which is significant compared to the WT and 
control morphant rates with a p-value of 0.0190 by the Log rank (Mantel-Cox) test (Fig. 
5B). Each treatment group initially consisted of 50 zebrafish and the survival curve 
performed in triplicate. 
p53 morphants had roughly 65% survival after the 6-day period (Fig. 5C). It was 
expected that coinjection of p53 MO and ncf1 MO would decrease ncf1 MO-induced off-
target effects. Hypothetically, this would cause the ncf1/p53 coinjection group to have the 
same, if not slightly increased, survival compared to the ncf1 MO group. This was not the 
case, with the p53 and ncf1/p53 MO groups having the same rate of survival (Fig. 5C). 
16 
 
Although appearing to have a slightly decreased survival rate of 65% compared to ncf1 
MO, the ncf1/p53 group was not significantly different with a p-value of 0.0775 (Fig. 
5C). Due to this, the p53 and ncf1/p53 groups were excluded from further study. 
 
 
 
 
 
 
 
 
 
 
 
Fig. 5 Survival of IAV or mock challenged zebrafish after morpholino treatment. A) HBSS vehicle 
control group survival. B) Survival of wild-type, control morpholino, and ncf1 morpholino IAV 
infected groups. ncf1 morphant fish have significantly higher rates of survival than wild-type fish 
when infected with influenza with a p-value of 0.0190. C) Comparison of p53 morphant, ncf1/p53 
morphant, and ncf1 morphant survival. IAV infected groups have lower rates of survival than HBSS 
injected counterparts with a p-value of <0.0001. 
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Fig. 6 ncf1 morphant fish 
have lowered neutrophil 
chemotaxis to IAV 
swimbladder infection than 
standard control morphants. 
Fluorescence confocal 
imaging of Tg(mpx:GFP) 
fish with mCherry color IAV 
at 48 hpi. Neutrophils are 
identified by green 
fluorescence and IAV 
infection by red 
fluorescence. A) Scrambled 
control morphant fish.  
B) ncf1 morphant fish. 
 
A 
B 
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ncf1 Morphant Fish Have Lowered Neutrophil Chemotaxis to Localized Sites of IAV 
Infection and Decreased Viral Burden During Systemic Infection Compared to  
Control Morphants 
 To qualitatively assess the neutrophil response to infection, fluorescence confocal 
images were taken of Tg(mpx:GFP) zebrafish injected with either scrambled control MO 
or ncf1 MO. Fish were infected with red fluorescent mCherry IAV at 72 hpf and imaged 
at 2 days post-infection. Neutrophils in scrambled control morphants have increased 
interaction between the virus compared to those of ncf1 morphant fish, exemplified by 
the increased amount of yellow in the image (Fig. 6). 
The Median Tissue Culture Infectious Dose (TCID50) is a method to quantify viral 
titer. It signifies the viral concentration at which 50% of cultured cells within a well plate 
are inoculated with a dilution of virus. TCID50 results yield decreased viral burden in ncf1 
morphants compared to scrambled control morphants by at least a factor of 10 at all time 
points over a span of 96 hours post infection (Fig. 7A). The largest disparity between 
ncf1 morphants and controls occurs at 24 hpi, at which viral burden decreases by a factor 
of 1000 (Fig. 7A). Cytopathic effects were observed as cell rounding and granularity, as 
well as grouping (Fig. 7B, 7C, and 7D). 
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Fig. 7 ncf1 morphants have decreased viral burden compared to standard control morphants. N = 2.  
A) Curve of TCID50/mL values over 96 hpi. B) Cell rounding cytopathic effect. C) Cell grouping 
cytopathic effect. D) Appearance of cytoplasmic inclusion bodies. E) Cells without cytopathic effects. 
 
 
ncf1 Morphants Exhibit Decreased nrf2, mxa, and cxcl8b Expression Compared to 
Control Morphants 
 To gauge gene expression changes in ncf1 mutants compared to controls at 24 hpi, 
qRT-PCR was conducted on nrf2, mxa, and cxcl8b. Nrf2 is an important regulator of the 
zebrafish antioxidant defense against ROS [26]. Mxa, also known as Myxovirus 
(Influenza) resistance A, is also of interest. Finally, Cxcl8b has been shown to be a 
regulator of neutrophil migration in zebrafish [27].  
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Fig. 8 Relative expression levels of nrf2, mxa, and cxcl8b treated with scrambled control and ncf1 
morpholinos with IAV and mock infection as measured by SYBR Green qRT-PCR. Graphs represent the 
mean fold change plus or minus standard error. N = 3. Significance between each comparison are p-values 
of 0.0257 (*), 0.0001 (***), and <0.0001 (****), respectively.  
 
 With IAV infection ncf1 morphant fish had decreased expression of each of the 
three genes compared to their control MO counterparts (Fig. 8). This indicates that ncf1 
expression has an impact on the innate antiviral response to IAV. 
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DISCUSSION 
 
 
  Influenza is responsible for over 650,000 deaths each year globally and 6 
pandemics since the late 1800s. In the United States alone, the CDC estimates that IAV 
causes anywhere between 140,000 to 810,000 hospitalizations per year. High-risk 
individuals are not only plagued by the virus, but are also burdened by a 
hyperinflammatory response by their own immune system, which can lead to lung 
epithelial tissue damage. Mechanisms involved in the innate neutrophil response and 
hyperinflammation are not fully characterized. Using an in vivo zebrafish model, this 
study aims to characterize the innate immune response to IAV infection with ncf1 
expression knockdown. 
 The first goal of this study was to characterize the survival of zebrafish with ncf1 
knockdown in response to systemic IAV infection. Compared to infected wild-type fish, 
ncf1 morphants had a significantly increased rate of survival after 6 days post-infection 
(dpi) (Fig. 5). The rate of survival was raised from about 55% to 75%, respectively. By 
inhibiting the ROS production of the NOX2 NADPH oxidase complex through MO 
knockdown of its key activating subunit, it is possible that the damaging, and lethal, 
hyperinflammatory response was decreased. 
 Knockdown of ncf1 during IAV infection may increase survival due to 
interference of viral pathways that lead to suppression of antiviral immune responses. 
Host-pathogen interaction mechanisms involving NOX2 may contribute to the increased 
survival of ncf1 morphants compared to controls. These survival findings are consistent 
with previous IAV studies [28] and observations of patients with chronic granulomatous 
disease with NCF1 mutations [29, 30]. Recently, research has indicated that IAV interacts 
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with the host immune response through Toll-like receptor-7 (TLR7)-dependent signaling 
to increase NOX2 activity [31]. TLR7 is an essential activator for B-cells and antibody 
production. NOX2 activation by IAV infection leads to the suppression of antiviral 
cytokines through the suppression of antibody production. This leads to a lowered ability 
of the host to clear viral infection and a lowered resistance to re-infection [31]. The 
impairment of this mechanism used by IAV could possibly lead to increased fish 
survival. There are likely many antiviral pathways affected by NOX2 activity during 
infection. Discovering the various mechanistic roles of NOX2/Ncf1 and their subsequent 
ROS signaling and cytokine pathways could provide novel therapeutic targets against 
damaging hyperinflammation and IAV infection.  
p53 morphants were analyzed as previous studies of other morphants showed off-
target effects, which could be reduced with use of a p53 morpholino [25]. Past research 
indicates that injecting with p53 morpholino does not significantly impact the initial 
survival of zebrafish and embryos are developmentally normal [32]. Due to this, it is 
expected that the p53 MO control group survival would not significantly deviate from 
that of the standard control and WT groups. Although the p53 MO control group did have 
increased survival compared to the WT and standard control MO groups, it was not 
significantly higher. It was also not significant from the ncf1/p53 coinjection group. 
Morpholino knockdown can be a contributing factor to decreased fish survival. Some 
morpholinos can induce apoptosis in morphants and the p53 morpholino has been shown 
to diminish off-target cell death [25]. In order to limit off-target effects and create accurate 
survival curves, another sample group was coinjected with both ncf1 and p53 MO. 
However, this did not prove to increase fish survival. Coinjecting p53 with ncf1 
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decreased survival by roughly 10% from ncf1 morpholino alone and was not significant 
from the aforementioned control groups (Fig. 5). Apoptosis is required to rid an organism 
of defective cells. Although the p53 morpholino was not expected to decrease survival, it 
is possible that by limiting apoptosis, there was increased stress and burden on the 
zebrafish, leading to lowered survival. 
 The second goal of this study aimed to characterize the general neutrophil 
response and viral burden of IAV infection in ncf1 morphant fish. The Kim lab has 
established the zebrafish swimbladder as a site for localized IAV infection. After 
infecting recombinant fluorescent Tg(mpx:GFP) fish at 4 dpf with mCherry color flu, 
confocal images were taken. This allowed us to qualitatively assess both neutrophil 
migration and interaction with IAV, as well as clearance of IAV over time. As expected, 
scrambled control morphant fish have a larger active neutrophil response to infection, 
with a high amount of interaction with the pathogen compared to their ncf1 morphant 
counterparts (Fig. 6). Surprisingly, even though ncf1 morphant fish had lowered 
neutrophil chemotaxis to the site of infection, shown by an increase of yellow indicating 
neutrophil-pathogen interaction in control morphants compared to ncf1 morphants, they 
also appeared to have a lower viral burden (Fig. 7). This brings to question the 
involvement of other phagocytic cells in the absence of a neutrophil response, namely 
macrophages. In the future, it would be of interest to use the Tg(mpeg1:dTomato), or 
another transgenic fluorescent macrophage zebrafish strain in order to visualize the 
macrophage response to IAV infection. If the neutrophil response is impaired, it may be 
possible that the innate immune system may try to compensate with other responding 
cells. 
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 Assessing viral titer over a span of 96 hpi further supports the qualitative results 
of the confocal imaging. Control morphants had an increase of viral titer reach a 
maximum height of 9.04x107 TCID50/mL at 24 hpi (Fig. 7A). However, ncf1 morphants 
only reached a maximum titer of 9.04x105 TCID50/mL at 48 hpi, a 1000-fold decrease 
compared to control morphants (Fig. 7A). Results were assessed by two individuals. 
Cytopathic effects were considered to be cell rounding, granularity, and grouping (Figs. 
7B, 7C, and 7D). To increase the accuracy of result interpretation, it would be beneficial 
to have a third person interpret the results. Another replicate of the experiment must also 
be conducted in order for the results to be statistically significant, as only 2 were 
performed. 
 Finally, this study aimed to begin to characterize the gene expression of select 
anti-inflammatory and antiviral regulators in response to a ncf1 knockdown. At 24 hpi, 
ncf1 morphants have decreased expression of nrf2, mxa, and cxcl8b compared to controls 
during IAV infection (Fig. 8). This is as expected. Nuclear factor (erythroid-derived 2) 2 
(Nrf2) is a key anti-inflammatory transcription factor in the innate immune system and 
has a direct relationship with Nox2 [33]. In order to combat the increase of ROS caused by 
the neutrophil antiviral response during IAV infection, Nrf2 would be normally be 
expressed at a high rate. The opposite seems to be true of the ncf1 KD zebrafish model. 
Without a functional NADPH oxidase complex to produce ROS, Nrf2 and its 
downstream antioxidants would not be required to fight hyperinflammation. In this 
knockdown model, they would not be induced at the same rate as without the KD during 
infection.  
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Strikingly, mxa, an interferon-stimulated gene, is downregulated in the ncf1 
morphants (Fig. 8). Research has shown that in Ncf1 deficient humans and mice, type I 
interferon signaling increases [34]. Type I signaling is one of the main inducers of MxA 
expression in humans [35]. However, preliminary data from the Benjamin King lab at the 
University of Maine has shown that although mxa is initially upregulated in an ncf1 KD 
zebrafish model of IAV infection, it quickly decreases after 6 hpi (Brandy Soos, 
unpublished). This data falls in line with these previous results, indicating that although 
there is an initial increase of type I signaling in the absence of ncf1 during infection, it 
subsides by 24 hpi. 
Interleukin 8 (IL-8) is encoded by the cxcl8 gene and is an important chemokine 
attractant of neutrophils used for chemotaxis through the bloodstream [27]. Although the 
expression of cxcl8b is markedly increased compared to that of nrf2 and mxa, it follows 
the same trend. This decrease in cxcl8b expression may be a contributing factor in the 
observed lowered neutrophil chemotaxis (Fig. 8). In the future, other CXC family genes 
associated with chemokine signaling should be investigated, such as cxcl4b. 
All 3 genes of interest are expressed at roughly half of the level in ncf1 morphants 
as they are in control morphants (Fig. 8), giving an initial insight into the genetic 
response to infection in this model. It is of interest to continue this aim by characterizing 
not only the first 24 hpi, but up to 96 hpi as well. Seeing the changes in gene expression 
over time would further serve to characterize the timeline of viral clearance in this KD 
model. 
 The improved survival and low viral burden of ncf1 morphants are likely 
influenced by many different factors. The decrease of ROS production would not only 
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decrease the amount of host tissue damage at sites of infection, but also lead to a loss of 
signaling initiated by IAV upon infection. Without this ROS signaling, IAV may be 
unable to utilize the host’s TLR7 signaling pathway to inhibit antiviral and antibody 
production. This should be confirmed in future studies by measuring downstream TLR7 
signaling in the ncf1 knockdown model. The phenotype could be further exacerbated by 
neutrophil modulation of other leukocytes. Macrophages are able to take on either pro-
inflammatory or anti-inflammatory phases, known as “M1” and “M2” respectively. M1 
macrophages will express an inducible nitric oxide synthase and produce signaling 
molecules such as TNF-α and IL-6 to protect against invading pathogens. M2 
macrophages facilitate host tissue repair and produce TGF-β and IL-10 signaling 
molecules. During infection, neutrophils have been shown to induce the macrophage M1 
phenotype for its pro-inflammatory response [36]. NOX2 has also been shown to drive 
M1-macrophage activity in a mouse model of neuroinflammation, while NOX2 inhibition 
increases IL-10 and anti-inflammatory signaling by macrophages [37, 38]. Although 
different than a zebrafish model of immunity, this data brings to question the 
contributions of neutrophil-modulated macrophage response during ncf1 KD and IAV 
infection.  
Chemical inhibition of NOX2 activity would be of interest in future study. 
Previous research has shown that diphenyleneiodonium (DPI) and VAS-2870 inhibition 
of NADPH oxidase activity blocks the suppression of CD4+ effector T cells by regulatory 
T cells [39]. DPI has been shown to be able to inhibit NOX isoforms in a dose-dependent 
manner, making it ideal to test with IAV infection [40]. If able to produce similar results as 
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ncf1 MO, this would suggest DPI and possibly other drug NOX2 inhibitors for future 
therapeutic studies. 
 There are many facets of this project that should be subject to further scrutiny. 
Although a MO model is easily accessible, its effects only last about 7 dpf. Also, a KD 
only impairs gene expression, it does not completely inhibit it. Repeating these 
experiments with a CRISPR knockout model would be more effective in characterizing 
the effects on the innate immune system without Ncf1. Future experiments to enhance 
this characterization may include the measurement of ROS production using a neutrophil-
specific respiratory burst assay, developed by the Kim lab at the University of Maine. 
Neutrophil migration should also be quantitatively analyzed to supplement the qualitative 
confocal imaging results. Further qRT-PCR should also be conducted, not only at the 
aforementioned time points but also for additional antioxidants, such as A1at and Sod1. 
Through this, more genetic targets may be identified for future therapies against IAV. 
Further research is needed to fully characterize the innate immune response to IAV in the 
absence of Ncf1 and provide targets for novel therapies for infection. 
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